Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Background and AimsThis study aimed at comparing the efficacy and safety of severe aplastic anemia (SAA) cases that had met the criteria for SAA at the time of diagnosis (group A) with SAA that had progressed from non-SAA (NSAA) (group B), both undergoing first-line immunosuppressive therapy (IST)....

Full description

Bibliographic Details
Main Authors: Limin Liu, Xin Zhao, Miao Miao, Yanming Zhang, Wenjing Jiao, Meiqing Lei, Huifen Zhou, Qingyuan Wang, Yifeng Cai, Liyun Zhao, Xiaohui Shangguan, Zefa Liu, Jinge Xu, Fengkui Zhang, Depei Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
severe aplastic anemia
immunosuppressive therapy
hematopoietic stem cell transplantation
first-line therapy
outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.739561/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.739561/full

Similar Items